DWA
BLFS icon

Dorsey Wright & Associates’s BioLife Solutions BLFS Stock Holding History

Dorsey Wright & Associates’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-577
Closed -$10K – 278
2019
Q3 		$10K Hold
577
– – ﹤0.01% 249
2019
Q2 		$10K Buy
577
+144
+33% +$2.51K ﹤0.01% 252
2019
Q1 		$8K Buy
+433
New +$6.89K ﹤0.01% 216

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
SCM
Sandler Capital Management New York $193M AUM 77.14% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Dorsey Wright & Associates's BLFS Position: Q4 2019 in Review

Dorsey Wright & Associates sold out of BioLife Solutions (BLFS) in Q4 2019, closing a stake of 577 shares — an estimated $10K sold.

Dorsey Wright & Associates first reported a position in BLFS in Q1 2019 and held it in 3 quarters. The position peaked at $10K in Q3 2019. 80 funds tracked by Wall St. Rank hold BLFS as of Q4 2019.

  • Dorsey Wright & Associates reported no remaining BioLife Solutions position as of Q4 2019 after selling out during the quarter.
  • Dorsey Wright & Associates sold 577 BioLife Solutions shares in Q4 2019, an estimated $10K.
  • Dorsey Wright & Associates first reported a position in BioLife Solutions in Q1 2019 and held it in 3 quarters.
  • Dorsey Wright & Associates's BioLife Solutions position peaked at $10K in Q3 2019.
  • 80 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2019.

Based on Dorsey Wright & Associates's 13F filing for Q4 2019, filed 31 Jan 2020.